Health experts are urging the NHS to provide comprehensive support for patients discontinuing obesity medications like Wegovy and Mounjaro. They recommend at least a year of follow-up care, including dietary advice and lifestyle support, to prevent weight regain. This call comes as concerns grow about the sustainability of weight loss achieved through these drugs without ongoing management. The experts emphasize that medication alone is not a long-term solution and that a holistic approach is crucial for maintaining a healthy weight after stopping the treatment.